These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3789915)

  • 1. Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas.
    Ettinghausen SE; Bonow RO; Palmeri ST; Seipp CA; Steinberg SM; White DE; Rosenberg SA
    Arch Surg; 1986 Dec; 121(12):1445-51. PubMed ID: 3789915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas.
    Dresdale A; Bonow RO; Wesley R; Palmeri ST; Barr L; Mathison D; D'Angelo T; Rosenberg SA
    Cancer; 1983 Jul; 52(1):51-60. PubMed ID: 6850545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography.
    Palmeri ST; Bonow RO; Myers CE; Seipp C; Jenkins J; Green MV; Bacharach SL; Rosenberg SA
    Am J Cardiol; 1986 Sep; 58(7):607-13. PubMed ID: 3751931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy of adult patients with soft tissue sarcomas.
    Rosenberg SA
    Important Adv Oncol; 1985; ():273-94. PubMed ID: 3916745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
    Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
    Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.
    Chang AE; Kinsella T; Glatstein E; Baker AR; Sindelar WF; Lotze MT; Danforth DN; Sugarbaker PH; Lack EE; Steinberg SM
    J Clin Oncol; 1988 Sep; 6(9):1491-500. PubMed ID: 3047339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
    Pisters PW; Patel SR; Prieto VG; Thall PF; Lewis VO; Feig BW; Hunt KK; Yasko AW; Lin PP; Jacobson MG; Burgess MA; Pollock RE; Zagars GK; Benjamin RS; Ballo MT
    J Clin Oncol; 2004 Aug; 22(16):3375-80. PubMed ID: 15310783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy.
    Dresdale AR; Barr LH; Bonow RO; Mathisen DJ; Myers CE; Schwartz DE; d'Angelo T; Rosenberg SA
    Am J Clin Oncol; 1982 Dec; 5(6):657-63. PubMed ID: 7165010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
    Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
    Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
    Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW
    J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.
    Antman K; Suit H; Amato D; Corson J; Wood W; Proppe K; Harmon D; Carey R; Greenberger J; Blum R
    J Clin Oncol; 1984 Jun; 2(6):601-8. PubMed ID: 6374055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities.
    Rosenberg SA; Tepper J; Glatstein E; Costa J; Young R; Baker A; Brennan MF; Demoss EV; Seipp C; Sindelar WF; Sugarbaker P; Wesley R
    Cancer; 1983 Aug; 52(3):424-34. PubMed ID: 6344981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
    Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
    Zalupski M; Metch B; Balcerzak S; Fletcher WS; Chapman R; Bonnet JD; Weiss GR; Ryan J; Benjamin RS; Baker LH
    J Natl Cancer Inst; 1991 Jul; 83(13):926-32. PubMed ID: 2067035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
    Wexler LH; Andrich MP; Venzon D; Berg SL; Weaver-McClure L; Chen CC; Dilsizian V; Avila N; Jarosinski P; Balis FM; Poplack DG; Horowitz ME
    J Clin Oncol; 1996 Feb; 14(2):362-72. PubMed ID: 8636745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of two methods of limb salvage in extremity soft-tissue sarcomas.
    Moseley HS
    Arch Surg; 1992 Oct; 127(10):1169-73; discussion 1173-4. PubMed ID: 1417481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas.
    Rosenberg SA
    Cancer Treat Rep; 1984 Sep; 68(9):1067-78. PubMed ID: 6383604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.